Assignee
NANJING ZHENGXIANG PHARMACEUTICALS CO LTD
CN·4 granted patents·3 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
7 records- 0168US11542262B2Phosphatidylinositol 3-kinase inhibitorsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2022·Granted Jan 3, 2023·0 cites·26 claims
- 0267US11673889B2Substituted imidazo[4,5-c][1,8]naphthyridines as phosphodiesterase inhibitorsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2022·Granted Jun 13, 2023·0 cites·17 claims
- 0364US11446301B2Quinoline analogs as phosphatidylinositol 3-kinase inhibitorsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2020·Granted Sep 20, 2022·0 cites·20 claims
- 0461US11466029B2Compounds useful to treat influenza virus infectionsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2022·Granted Oct 11, 2022·0 cites·18 claims
- 0560US2023014730A1Phosphodiesterase inhibitors and useNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0658US2023227446A9Phosphatidylinositol 3-kinase inhibitorsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0753US2022033416A1Compounds useful to treat influenza virus infectionsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NANJING ZHENGXIANG PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →